Cadrenal Therapeutics effects 1-for-15 reverse stock split to meet Nasdaq $1 minimum bid price

Cadrenal Therapeutics, Inc.

Reverse stock split at 1-for-15 effective 12:01 a.m. ET on August 20, 2024; shares reduced from ~16 million to ~1.1 million.
No fractional shares issued; holders of fractional shares receive cash based on 10-day average closing price before effective time.
Split intended to bring common stock (CVKD) into compliance with Nasdaq's $1.00 minimum bid price requirement.
New CUSIP number for common stock is 127636207; proportional adjustments made to outstanding equity awards and warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.